|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/06 | (2018.01) |
| C07D 207/08 | (2006.01) | ||
| C07D 207/26 | (2006.01) | ||
| C07D 211/22 | (2013.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07D 211/22 | (2006.01) | ||
| C07D 213/48 | (2013.01) | ||
| C07D 211/76 | (2006.01) | ||
| C07D 213/48 | (2006.01) | ||
| C07D 207/26 | (2013.01) | ||
| C07D 223/04 | (2006.01) | ||
| C07D 265/30 | (2013.01) | ||
| C07D 265/30 | (2006.01) | ||
| C07D 405/04 | (2013.01) | ||
| C07D 279/12 | (2006.01) | ||
| C07D 417/04 | (2013.01) | ||
| C07D 307/46 | (2006.01) | ||
| C07D 413/04 | (2013.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 307/46 | (2013.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 401/06 | (2013.01) | ||
| C07D 405/04 | (2006.01) | ||
| C07D 223/04 | (2013.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07D 405/12 | (2013.01) | ||
| C07D 207/08 | (2013.01) | ||
| C07D 413/04 | (2006.01) | ||
| C07D 211/76 | (2013.01) | ||
| C07D 417/04 | (2006.01) | ||
| C07D 279/12 | (2013.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61K 31/40 | (2006.01) |
| (11) | Number of the document | 3860975 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19787545.3 |
| Date of filing the European patent application | 2019-09-30 | |
| (97) | Date of publication of the European application | 2021-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/053862 |
| Date | 2019-09-30 |
| (87) | Number | WO 2020/072377 |
| Date | 2020-04-09 |
| (30) | Number | Date | Country code |
| 201862739757 P | 2018-10-01 | US | |
| 201962821311 P | 2019-03-20 | US |
| (72) |
METCALF, Brian W. , US
LI, Zhe , US
XU, Qing , US
DUFU, Kobina N. , US
PARTRIDGE, James , US
SHAM, Hing , US
YU, Ming , US
|
| (73) |
Global Blood Therapeutics, Inc. ,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (54) | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE |
| MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE |